Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.22 USD | +2.13% | -2.51% | +23.17% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.17% | 762M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- H.C. Wainwright Adjusts Price Target on WAVE Life Sciences to $15 From $8, Maintains Buy Rating